[Study of flunitrazepam in a psychiatric practice].
D000075:Acepromazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001463:Barbiturates / Q000627:therapeutic use; D003009:Clorazepate Dipotassium / Q000627:therapeutic use; D004338:Drug Combinations; D004361:Drug Tolerance; D005445:Flunitrazepam / Q000627:therapeutic use*; D006801:Humans; D008620:Meprobamate / Q000627:therapeutic use; D008702:Methaqualone / Q000627:therapeutic use; D009567:Nitrazepam / Q000627:therapeutic use; D011567:Psychiatric Department, Hospital; D011799:Quinazolines / Q000627:therapeutic use; D012890:Sleep / Q000187:drug effects; D019966:Substance-Related Disorders; D013997:Time Factors
D014151:Anti-Anxiety Agents; D001463:Barbiturates; D004338:Drug Combinations; D011799:Quinazolines; D000075:Acepromazine; D005445:Flunitrazepam; D003009:Clorazepate Dipotassium; D008702:Methaqualone; D009567:Nitrazepam; D008620:Meprobamate
Etude du flunitrazépam en clientèle psychiatrique.